The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.
ACS Cent Sci. 2022 Apr 27;8(4):449-460. doi: 10.1021/acscentsci.1c01479. Epub 2022 Mar 17.
ACS Cent Sci. 2022.
PMID: 35559427
Free PMC article.